- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Can They Turn the Tide
Global Pharmaceuticals & Biotech Can They Turn the Tide
UPDATED Jul 19, 2022
Annually loss-making mid-caps and large-caps with sound financial health.
38 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CVACCureVac | US$13.93 | 5.2% | -73.5% | US$2.6b | US$25.75 | PS21.7x | E39.2% | n/a | ||
| RLAYRelay Therapeutics | US$20.56 | 6.4% | -40.1% | US$2.2b | US$38.88 | PS895.1x | E-3.7% | n/a | ||
| TWSTTwist Bioscience | US$43.46 | 7.0% | -64.2% | US$2.4b | US$41.83 | PS15x | E-2.6% | n/a | ||
| TXG10x Genomics | US$36.67 | -23.1% | -79.8% | US$4.2b | US$79.29 | PS8.3x | E101.8% | n/a | ||
| LEGNLegend Biotech | US$51.88 | -6.3% | 13.2% | US$8.0b | US$68.13 | PS67.2x | E64.4% | n/a | ||
| BGNEBeiGene | US$178.36 | -0.2% | -43.8% | US$18.4b | US$304.39 | PS21x | E45.9% | n/a | ||
| BEAMBeam Therapeutics | US$64.61 | 22.2% | -31.9% | US$4.4b | US$92.25 | PS73.7x | E-13.9% | n/a | ||
| ARWRArrowhead Pharmaceuticals | US$42.67 | 2.8% | -37.2% | US$4.5b | US$76.83 | PS17.1x | E39.9% | n/a | ||
| ONTOxford Nanopore Technologies | UK£3.00 | 2.9% | n/a | UK£2.5b | UK£5.80 | PS18.5x | E33.9% | n/a | ||
| ARVNArvinas | US$51.92 | 6.5% | -32.8% | US$2.8b | US$100.05 | PS42.2x | E15.4% | n/a | ||
| ZLABZai Lab | US$43.21 | 14.6% | -73.3% | US$4.2b | US$101.69 | PS24.7x | E52.1% | n/a | ||
| CYTKCytokinetics | US$39.98 | -10.4% | 37.0% | US$3.4b | US$62.85 | PS52.7x | E28.3% | n/a | ||
| ASNDAscendis Pharma | US$87.94 | -2.4% | -28.0% | US$4.9b | US$145.91 | PS345.8x | E41.8% | n/a | ||
| CERECerevel Therapeutics Holdings | US$27.56 | 3.0% | 22.6% | US$4.1b | US$40.29 | PB7.8x | E-10.8% | n/a |